Clinical Trial: A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258979) titled 'A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.' on Nov. 17.

Brief Summary: This is a multicenter, open-label, Phase Ib/II study conducted in China to evaluate the safety, efficacy, and pharmacokinetic (PK) characteristics of YL201 combined with Toripalimab (doublet regimen) or YL201 combined with Toripalimab and Cisplatin (triplet regimen) in subjects with recurrent or metastatic nasopharyngeal carcinoma.

Study Start Date: Nov. 05

Study Type: INTERVENTIONAL

Condition: Recurrent or Metastatic Nasopharyngeal Carcinoma

Intervention: DRUG: YL201

YL201 will be administere...